The Scientific Advisory Group / EFSA Panel / ECDC / Shimizu / /
Continent
Asia / North America / Europe / /
Country
Germany / Netherlands / Slovenia / Sweden / Belgium / France / Japan / Austria / United States / Canada / Denmark / / /
Event
Business Partnership / /
Facility
Canary Wharf / Belgium MRSA CC398 spa / / /
IndustryTerm
prevention of mainly respiratory and digestive disorders / food producing animals / intensive animal production systems / food producing / animal-derived food products / food animal species / veterinary medicinal products / servlet / food production / altered target site / food intoxications / /
MedicalCondition
postoperative infections / aggressive soft tissue infection / bovine S. aureus / clinical MRSA infection / dermatitis / septicaemia / mainly respiratory and digestive disorders / post-weaning dermatitis / toxic shock syndrome / severe and economically-important diseases / severe infections / epidemics / invasive infections / nosocomial infections / infections / Belgian bovine clinical and subclinical mastitis / MRSA infection / pneumonia / lesser extent infections / estimated infection / diabetes / S. aureus / mastitis / skin and soft tissue infections ( ssti ) / endocarditis / infection / quality data investigating infection / clinical infections / Surgical site infections / bovine mastitis / /
MedicalTreatment
Antibiotics / dialysis / /
Organization
Federation of Veterinarians of Europe / European Medicines Agency / Dutch hospital / European Commission / European Union / COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE / /
Microsoft Word - Reflection paper MRSA